Founded in 1998500+ safe and successful trialsExemplary safety recordCutting-edge technologyPhase I specialist
Amplimmune
Amplimmune Inc. operates as a biotechnology company. The Company develops immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation, and infectious diseases.
Website: https://www.astrazeneca.com/